A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment

CONCLUSION: Long-term treatment with raloxifene in women with osteoporosis was not significantly associated with a reduction in breast cancer rates. However, further investigation is required for a conclusive proof.PMID:34128366 | DOI:10.4048/jbc.2021.24.e28

Source: Journal of Breast Cancer - June 15, 2021 Category: Cancer & Oncology Authors: Jihyoun Lee Ji Sung Lee Jong Eun Lee Zisun Kim Sun Wook Han Sung Mo Hur Young Jin Choi Sungmin Park Source Type: research